Sylvain Sachot

Sylvain Sachot is a partner at Asabys Partners since November 2018 and has held various roles including principal and investment director. Additional current positions include board member at Gradient Denervation Technologies and Orikine Bio, board observer at SpliceBio, Anaconda BioMed, MedLumics, S.L., and INBRAIN Neuroelectronics, and board director at Anaconda BioMed. Previously, Sylvain Sachot served as a board observer at Anaconda BioMed from May 2017 to November 2018 and worked as an investment associate at Ysios Capital from July 2015 to November 2018. Earlier experience includes a role as a business analyst at Vall d’Hebron Institute of Research from September 2014 to July 2015. Sylvain Sachot holds an MBA in Business Administration and Management from Esade, a PhD in Biology - Biochemistry - Molecular Biology from Nantes Université, and a Master's in Biotechnology from Université Paris-Est Créteil.